Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$93.41 -1.80 (-1.90%)
At close: Oct 1, 2026 · 4:00 PM EDT

Rhythm Pharmaceuticals (RYTM) Non Operating Interest Expenses (2022 - 2026)

Updated

Rhythm Pharmaceuticals' Non Operating Interest Expenses came in at $4.54 million for Q2 2026, down 22.0% from $5.82 million a year earlier and down 0.9% from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Rhythm Pharmaceuticals reported Non Operating Interest Expenses of $18.48 million, down 15.7% year-over-year; for FY2025, it was $20.58 million, down 0.1% from FY2024.

  • Non Operating Interest Expenses carries a three-year compound annual growth rate of 58.2% (FY2022 to FY2025).
  • Going back by year, Non Operating Interest Expenses was $20.6 million in FY2024 (+48.3%), $13.89 million in FY2023 (+167.1%) and $5.2 million in FY2022.
  • The Q2 2026 figure represents the lowest quarterly Non Operating Interest Expenses since Q3 2023.
  • Year-over-year, Non Operating Interest Expenses has declined for four consecutive quarters, with growth averaging 8.0% over the last eight quarters.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q3 2024 (growth of 66.5%), and the weakest in Q2 2026 (a decline of 22.0%).
  • Business Quant data shows RYTM's Non Operating Interest Expenses at $4.58 million (Q1 2026), $4.62 million (Q4 2025) and $4.74 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Rhythm Pharmaceuticals 6.55 Bn 5.42 Bn 62.32 Mn 4.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.54 Mn
Mar 31, 2026 4.58 Mn
Dec 31, 2025 4.62 Mn
Sep 30, 2025 4.74 Mn
Jun 30, 2025 5.82 Mn
Mar 31, 2025 5.41 Mn
Dec 31, 2024 5.45 Mn
Sep 30, 2024 5.24 Mn
Jun 30, 2024 4.60 Mn
Mar 31, 2024 4.76 Mn
Dec 31, 2023 4.55 Mn
Sep 30, 2023 3.15 Mn
Jun 30, 2023 3.30 Mn
Mar 31, 2023 3.06 Mn
Dec 31, 2022 3.01 Mn
Sep 30, 2022 2.14 Mn
Jun 30, 2022 46,000.00
API Access

Rhythm Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RYTM&period=max&api_key=YOUR_API_KEY